After hours: October 14 at 5:49 PM EDT Loading Chart for TNDM ...

Analyst Jeff Johnson from Robert W. Baird reiterated a Hold rating on Tandem Diabetes Care (TNDM – Research Report) and increased the price target to $39.00 from $0.00. Jeff Johnson has given ...

SAN DIEGO, September 19, 2024--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin ...

On Friday, Goldman Sachs initiated coverage on Tandem Diabetes Care (NASDAQ:TNDM) stock, a medical device company specializing in insulin pumps, with a Neutral rating and a price target of $46.00.

Analysts' ratings for Tandem Diabetes Care (NASDAQ:TNDM) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The table below provides a snapshot of their recent ratings ...

Tandem Diabetes Care (NASDAQ: TNDM) had some encouraging news to report on the regulatory front Thursday, and after it hit ...

The prognosticator behind that piece of bad news was Citigroup's Joanne Wuensch, who issued one of her bank's 90-day catalyst watches on Tandem stock before the market open. Wuensch wrote in her ...

In its press release trumpeting the EU's move, Tandem quoted its chief medical officer Jordan Pinsker as saying, "Ultra-rapid-acting insulin is a popular choice for people living with diabetes due ...